Glycosylation-dependent modulation of the lL-2 signaling axis determines Th17 differentiation and IL-10 production
Leona GabryšováiD, Elizabeth H. Mann, Lydia Bradley, James I. MacRae, Charlotte Whicher, Catherine M. Hawrylowicz, Dimitrios Anastasiou, Anne O’Garra
Abstract
Metabolism plays an essential role in shaping T helper (Th) cell responses including the production of pro-inflammatory cytokines, however the effects on IL-10 have not been investigated. We show that the glucose analogue 2-deoxyglucose (2DG) specifically inhibits Th1 and Th2 cell differentiation and accompanying IL-10 production. In contrast, 2DG promotes IL-17A production by Th17 cells, even in the presence of IL-2 known to limit Th17 differentiation, whilst totally abrogating the production of IL-10. Notably, rather than inhibiting glycolysis, 2DG acts through the inhibition of glycosylation, which is critical for IL-2R surface expression and downstream signaling in both mouse and man. Strikingly, IL-2 is essential for IL-10 production by Th17 cells, in contrast to its inhibitory effect on the production of IL-17A. Our study reveals a previously unappreciated, anti-inflammatory role for IL-2 in Th17 cell production of IL-10 and thus identifies a novel mechanism to limit Th17 pathogenicity.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modulation of glucose metabolism by 2-Deoxy-D-Glucose (2DG) promotes IL-17 producing human T cell subsets
X. Chen, L. Kozhaya, … D. Unutmaz·bioRxiv·Mar 13, 2022
- The glycolytic reaction PGAM unexpectedly restrains Th17 pathogenicity and Th17-dependent autoimmunity
Chao Wang, Allon Wagner, … Vijay Kumar Kuchroo·Cell ReportsPeer-reviewed·Jun 1, 2025
- O-GlcNAcylation and low glycolysis underpin Th2 polarization by dendritic cells
Leonard R. Pelgrom, Marjolein Quik, … Bart Everts·bioRxiv·Feb 5, 2026
- Glycolytic flux sustains human Th1 identity and effector function via STAT1 glycosylation
Ariful Haque Abir, Julia Benz, … Dirk Mielenz·Life Science AlliancePeer-reviewed·Oct 22, 2025
- Niche-selective inhibition of pathogenic Th17 cells by targeting metabolic redundancy
L. Wu, K. E. R. Hollinshead, … D. R. Littman·bioRxiv·Jun 10, 2020
- Akt2 deficiency impairs Th17 differentiation, augments Th2 differentiation, and alters the peripheral response to immunization
Lauren Baker Banks, Tammarah Sklarz, … Martha S. Jordan·bioRxiv·Jun 7, 2024